Aspire Biopharma Files Investor Presentation (Aug 19, 2026)

What Happened
Aspire Biopharma Holdings, Inc. (ASBP) filed a Form 8-K on August 19, 2026 to furnish an investor presentation under Item 7.01 (Regulation FD Disclosure). The presentation is included as Exhibit 99.1 and is dated August 19, 2026. The filing also includes the Inline XBRL cover page as Exhibit 104.

Key Details

• Filing date: August 19, 2026 (Form 8-K).
• Item 7.01: Investor presentation furnished under Regulation FD; included as Exhibit 99.1 (dated Aug 19, 2026).
• Item 9.01: Exhibits listed include 99.1 (Investor Presentation) and 104 (Cover Page Interactive Data File / Inline XBRL).

Why It Matters
Furnishing an investor presentation under Regulation FD means Aspire is broadly disclosing information to the public—investors should review the presentation for any updates on the company’s business, strategy, pipeline, or financial outlook. This 8-K does not itself report earnings or executive changes; it simply makes the presentation available as a public disclosure. Check the attached Exhibit 99.1 for specifics and monitor future filings for any related material updates.